Azenta, Inc. (AZTA)
NASDAQ: AZTA · Real-Time Price · USD
28.71
+1.94 (7.25%)
May 12, 2025, 1:58 PM - Market open
Revenue by Product
Fiscal year is October - September.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2019 |
|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | 2017 - 2019 |
| Sample Management Solutions |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sample Management Solutions Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Life Sciences Products |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Life Sciences Products Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Life Sciences Services |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Life Sciences Services Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Multiomics |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Multiomics Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Core Products |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Core Products Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sample Repository Solutions |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sample Repository Solutions Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| B Medical |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| B Medical Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is October - September.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2019 |
|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | 2017 - 2019 |
| North America |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North America Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia Pacific/ Other |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia Pacific/ Other Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Africa |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Africa Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United Kingdom |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United Kingdom Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of Europe |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of Europe Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is October - September.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | NaN - NaN |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | NaN - NaN |
| Sample Management Solutions Adjusted Operating Income | 20.42M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sample Management Solutions Adjusted Operating Income Growth | -416.61% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Multiomics Adjusted Operating Income | -9.20M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Multiomics Adjusted Operating Income Growth | 83.89% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| B Medical Systems Adjusted Operating Income | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| B Medical Systems Adjusted Operating Income Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Life Sciences Product Adjusted Operating Income | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Life Sciences Product Adjusted Operating Income Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Life Sciences Services Adjusted Operating Income | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Life Sciences Services Adjusted Operating Income Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Organic Revenue Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|